Immunogenicity of Edmonston-Zagreb measles vaccine
Parmar, V.R.; Sood, A.K.; Goyal, A.; Sharma, V.; Singh, T.
Indian Pediatrics 33(10): 845-850
1996
ISSN/ISBN: 0019-6061 PMID: 9057383 Document Number: 459020
Document emailed within 1 workday
Related Documents
Rogers, S.; Sanders, R.C.; Alpers, M.P. 1991: Immunogenicity of standard dose Edmonston-Zagreb measles vaccine in highland Papua new Guinean children from four months of age Journal of Tropical Medicine and Hygiene 94(2): 88-91Fowlkes, A.; Witte, D.; Beeler, J.; Audet, S.; Garcia, P.; Curns, A.; Yang, C.; Fudzulani, R.; Broadhead, R.; Bellini, W.J.; Cutts, F.; Helfand, R.F. 2011: Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi Journal of Infectious Diseases 204(Suppl 1): S149-S157
Martins, C.; Garly, M-Lill.; Bale, C.; Rodrigues, A.; Benn, C.S.; Whittle, H.; Aaby, P. 2013: Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines Vaccine 31(48): 5766-5771
abu Eldan, J.; Borćić, B.; Smerdel, S. 1991: Persistence of immunity against measles in persons immunized with Edmonston-Zagreb vaccine Acta medica Croatica: casopis Hravatske akademije medicinskih znanosti 45(4-5): 297-304
Bahl, R.; Kumar, R.; Bhandari, N.; Kant, S.; Srivastava, R.; Bhan, M.K. 1999: Vitamin a administered with measles vaccine to nine-month-old infants does not reduce vaccine immunogenicity Journal of Nutrition 129(8): 1569-1573
da Silveira, C.Marcos.; Kmetzsch, C.Iris.; Mohrdieck, R.; Sperb, A.Fagundes.; Prevots, D.Rebecca. 2002: The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997 International Journal of Epidemiology 31(5): 978-982
Gatchalian, S.; Tabora, C.; Bermal, N.; Leboulleux, D.; Desauziers, E. 2004: Immunogenicity and safety of a varicella vaccine (Okavax) and a trivalent measles, mumps, and rubella vaccine (Trimovax) administered concomitantly in healthy Filipino children 12-24 months old American Journal of Tropical Medicine and Hygiene 70(3): 273-277
Ninashvili, N.Z.; Gelikman, B.G.; Shavdiia, N.T.; Elikashvili, M.I.; Gogokhia, T.N. 1993: The assessment of the immunogenicity of different batches of live L-16 measles vaccine in urban and rural localities Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 72-74
Gatchalian, S.; Cordero-Yap, L.; Lu-Fong, M.; Soriano, R.; Ludan, A.; Chitour, K.; Bock, H.L. 1999: A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age Southeast Asian Journal of Tropical Medicine and Public Health 30(3): 511-517
He, H.; Chen, E.; Chen, H.; Wang, Z.; Li, Q.; Yan, R.; Guo, J.; Zhou, Y.; Pan, J.; Xie, S. 2014: Similar immunogenicity of measles-mumps-rubella (MMR) vaccine administrated at 8 months versus 12 months age in children Vaccine 32(31): 4001-4005
Tikhonova, N.T.; Khrometskaia, T.M.; Livanova, L.V.; Poliakova, T.A.; Azarova, S.A. 1978: Several indices of humoral anti-measles immunity in children, previously immunized with live measles vaccine, who have developed measles Voprosy Virusologii 3: 322-327
Olila, D.; Olwa-Odyek; Opuda-Asibo, J. 2002: Screening extracts of Zanthoxylum chalybeum and Warburgia ugandensis for activity against measles virus (Swartz and Edmonston strains) in vitro African Health Sciences 2(1): 2-10
Makino, S.; Sasaki, K.; Nakamura, N.; Nakagawa, M.; Nakajima, S. 1974: Studies on the modification of the live AIK measles vaccine. II. Development and evaluation of the live AIK-C measles vaccine Kitasato Archives of Experimental Medicine 47(1-2): 13-21
Techasena, W.; Sriprasert, P.; Pattamadilok, S.; Wongwacharapipoon, P. 2007: Measles antibody in mothers and infants 0-2 years and response to measles vaccine at the age of 9 and 18 months Journal of the Medical Association of Thailand 90(1): 106-112
Modlin, J.F.; Jabbour, J.T.; Witte, J.J.; Halsey, N.A. 1977: Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis Pediatrics 59(4): 505-512
Kanbur, N.Oksüz.; Derman, O.; Kutluk, T. 2005: Measles seroprevalence of an adolescent population vaccinated with a single dose of measles vaccine before their first birthday International Journal of Adolescent Medicine and Health 17(4): 337-341
Markowitz, L.E.; Nieburg, P. 1991: The burden of acute respiratory infection due to measles in developing countries and the potential impact of measles vaccine Reviews of Infectious Diseases 13(Suppl): S555-S561
Hutchins, S.S.; Escolan, J.; Markowitz, L.E.; Hawkins, C.; Kimbler, A.; Morgan, R.A.; Preblud, S.R.; Orenstein, W.A. 1989: Measles outbreak among unvaccinated preschool-aged children: opportunities missed by health care providers to administer measles vaccine Pediatrics 83(3): 369-374
Miura, S. 1968: Effects of the combined administration of a triple vaccine of pertussis, diphtheria and tetanus and virus vaccine (live polio vaccine or inactivated measles vaccine) on immunity to pertussis, diphtheria and tetanus. 1. Results of the initial immunization Nihon Shonika Gakkai Zasshi. Acta Paediatrica Japonica 72(6): 767-781
Lin, T.-Y.; Wang, Y.-H.; Chang, L.-Y.; Chiu, C.-H.; Huang, Y.-C.; Tang, H.; Bock, H.L. 2003: Safety and immunogenicity of a diphtheria, tetanus, and acellular pertussis-inactivated poliovirus vaccine/Haemophilus influenzae type B combination vaccine administered to Taiwanese infants at 2, 4, and 6 months of age Chang Gung Medical Journal 26(5): 315-322